CV Risk: Clinical Trials

2 completed, 1 recruiting. 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	1	Recruiting 1

Follow CV Risk: new trials by email Literature Review of CV Risk trials Research Report on CV Risk

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe) Cardio-Oncology Referral, Notification to PCP/General Cardiologist - Prostate Cancer (Diagnosis), Prostate Cancer Stage IV	Phase 2	Recruiting	Cedars-Sinai Medical Center	80	2026-07-15	2026-10-05
National Tunisian Clinical Registry on CardioVascular Secondary Prevention Clinical Secondary Prevention, CHD		Completed	Dacima Consulting	7284	2025-06-09	2026-05-11
Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects Type 2 Diabetes Mellitus, CV Risk		Completed	GlaxoSmithKline	1100	2004-03-01	2008-10-15

Narrower conditions

Diabetes Mellitus, Type 2 (1)  ·  Disease (1)  ·  Prostatic Neoplasms (1)

Broader conditions

Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Glucose Metabolism Disorders (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Prostatic Diseases (1)  ·  Urogenital Diseases (1)

Sponsors

Cedars-Sinai Medical Center (1)  ·  Dacima Consulting (1)  ·  GlaxoSmithKline (1)

Countries

Tunisia (1)  ·  United States (1)

Top investigators

Ihsen Zairi, MD (1)  ·  Katelyn Atkins, MD, PhD (1)  ·  Leslie Ballas, MD (1)  ·  Salma Charfeddine, MD (1)  ·  Youssef Ben Ameur, MD (1)